BC Innovations | Aug 29, 2019
Distillery Therapeutics

Destabilizing HDGF through NSUN2-YBX1 signaling inhibition for bladder cancer

DISEASE CATEGORY: Cancer INDICATION: Bladder cancer Destabilizing the oncogene HDGF by inhibiting NSUN2-YBX1 signaling could treat bladder cancer. In 199 bladder cancer patients, high tumor levels of HDGF, NSUN2 and YBX1 were associated with poor...
Items per page:
1 - 1 of 1